The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Omega-3 polyunsaturated fatty acids and docosahexaenoic acid appear to be associated with lower age-related macular ...

The processing of optical information in the retina of the eye, where the light-sensitive photoreceptors and the first nerve ...

Soliddd Corp., a New York City-based optical and vision technology company, introduced its SolidddVision smart glasses ...

Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic ...

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration. This groundbreaking study, ...

EyeFortin is intricately fabricated to support strong vision and to promote healthy functioning of the eyes. It contains ...

Updates on commercial insights and readiness plans for sozinibercept in wet AMDOpthea management to present in New York City on Tuesday, January ...

New research from the Guangdong Academy of Medical Sciences has found that certain eye conditions, like age-related macular ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...